QMA

Fresenius Medical Care AG & Co. KGaA (FMS) — QMA analysis

Sector: Healthcare · Market cap: $13.8B · Price: $22.23 · Data as of 2026-10-22

65
/100
A
Composite grade
Higher score than 96% of 22,733 tracked stocks

Fresenius Medical Care AG & Co. KGaA has an above-average composite score of 65/100, higher score than 96% of 22,733 tracked stocks. The highest-scoring layer is Catalysts; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.
Share this analysis
𝕏in

What 12 data layers say about FMS

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)78/100
Earnings quality (EQS)73/100
Technical trend (TSS)47/100
Relative strength (RS)53/100
Momentum (USS)51/100
Insider activity (IAS)0/100
Off-exchange trading (FINRA) / large flows (WHS)32/100
Institutional 13F (IFS)65/100
Options flow (OFS)53/100
News sentiment (NSS)58/100
Analysts / transcripts (ATS)55/100
Catalysts (XS)93/100

What does the QMA model currently show for Fresenius Medical Care AG & Co. KGaA?

The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.

For FMS the layers diverge — some score high (Catalysts), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

FMS insider & smart money activity

For FMS we track the institutional footprint through FINRA off-exchange trading data (WHS 32/100) and reported 13F positions, filed with up to a 45-day delay (IFS 65/100). Detailed insider data for this stock is still being collected.

FMS seasonality

The historically strong window for FMS was April 1–28 with a hit rate of 67% and an average move of 3.3% (21 years of history).

Historical data does not guarantee future results.

FMS dividend

Fresenius Medical Care AG & Co. KGaA currently carries a dividend yield of 3.89% and has paid for 29 years in a row.

How FMS compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for FMS stock?

65/100 (grade A) as of 2026-10-22, fusing 12 data layers. An analytical score, not advice.

Are insiders buying FMS stock?

Detailed insider data is still being collected.

Where can I see live FMS data?

Live FMS data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Explore more — for free

The FMS score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.

Free registration, no card — trial full access, then the free plan

Want the full FMS analysis with all layers and live data? Open FMS detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]